Literature DB >> 21437724

Laser welding of vesicovaginal fistula--outcome analysis and long-term outcome: single-centre experience.

Prem N Dogra1, Ashish K Saini.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of this study is to evaluate the efficacy and safety of laser welding of vesicovaginal fistula (VVF) at our centre.
METHODS: Between January 1, 2001 and January 3, 2010, eight patients underwent laser welding of vesicovaginal fistula. The mean age was 44 years (35-55). The VVF were primary (failing to heal following conservative management) in five and secondary (recurring following primary repair) in three cases. The mean fistula size was 3 mm (range, 2-4). Neodymium yttrium aluminium garnet (YAG) laser was used for the initial case, and in the remaining seven cases, holmium YAG laser was used for circumferential welding of the fistula. Following the procedure, a catheter was kept for 3 weeks. The mean hospitalisation period was 1 day. The mean follow-up is 47 months (2-110).
RESULTS: Seven patients were dry after catheter removal. In one patient, procedure was abandoned due to bleeding.
CONCLUSIONS: Laser welding of VVF is a simple, safe and efficacious procedure in a select group of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21437724     DOI: 10.1007/s00192-011-1389-0

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  10 in total

1.  Nonsurgical closure of vesicovaginal fistulas.

Authors:  H C FALK; L A ORKIN
Journal:  Obstet Gynecol       Date:  1957-05       Impact factor: 7.661

Review 2.  Laser tissue welding: a urological surgeon's perspective.

Authors:  D P Poppas; D S Scherr
Journal:  Haemophilia       Date:  1998-07       Impact factor: 4.287

3.  Sutureless microvascular anastomosis using the THC:YAG laser: a preliminary report.

Authors:  L S Bass; M R Treat; C Dzakonski; S L Trokel
Journal:  Microsurgery       Date:  1989       Impact factor: 2.425

4.  Fibrin occlusion of a vesicovaginal fistula.

Authors:  S Pettersson; H Hedelin; I Jansson; A C Teger-Nilsson
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

5.  Full-thickness Martius grafts to preserve vaginal depth as an adjunct in the repair of large obstetric fistulas.

Authors:  T Margolis; T E Elkins; J Seffah; H S Oparo-Addo; D Fort
Journal:  Obstet Gynecol       Date:  1994-07       Impact factor: 7.661

6.  Genitourinary fistulas: vaginal approach for repair of vesicovaginal fistulas.

Authors:  P E Zimmern; H R Hadley; D Staskin; S Raz
Journal:  Clin Obstet Gynaecol       Date:  1985-06

7.  Fibrin occlusion of fistulas postoperatively.

Authors:  H Hedelin; A E Nilson; A C Teger-Nilsson; G Thorsen
Journal:  Surg Gynecol Obstet       Date:  1982-03

8.  Laser welding of vesicovaginal fistula.

Authors:  P N Dogra; G Nabi
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

9.  Initial human evaluation of argon laser-assisted vascular anastomoses.

Authors:  R A White; G H White; R M Fujitani; J W Vlasak; C E Donayre; G E Kopchok; S K Peng
Journal:  J Vasc Surg       Date:  1989-04       Impact factor: 4.268

10.  Use of electrocoagulation in the treatment of vesicovaginal fistulas.

Authors:  M D Stovsky; J M Ignatoff; M D Blum; J B Nanninga; V J O'Conor; E D Kursh
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

  10 in total
  3 in total

1.  Vesicovaginal fistula: what is the preferred closure technique?

Authors:  Edward Stanford; Lauri Romanzi
Journal:  Int Urogynecol J       Date:  2011-12-08       Impact factor: 2.894

2.  Management of a vesicovaginal fistula using holmium laser ablation.

Authors:  Ruchira Singh; Jennifer J Schmitt; John J Knoedler; John A Occhino
Journal:  Int Urogynecol J       Date:  2016-03-24       Impact factor: 2.894

Review 3.  Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: A systematic review and meta-analysis.

Authors:  Barbara Bodner-Adler; Engelbert Hanzal; Eleonore Pablik; Heinz Koelbl; Klaus Bodner
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.